Fibromuscular dysplasia CT

Jump to navigation Jump to search

Fibromuscular dysplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fibromuscular dysplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiorgram

X-ray

CT

MRI

Arteriography

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Management Guidelines

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

ASA/ACCF/AHA Guideline Recommendations

Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries

Case Studies

Case #1

Fibromuscular dysplasia CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fibromuscular dysplasia CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fibromuscular dysplasia CT

CDC on Fibromuscular dysplasia CT

Fibromuscular dysplasia CT in the news

Blogs on Fibromuscular dysplasia CT

Directions to Hospitals Treating Fibromuscular dysplasia

Risk calculators and risk factors for Fibromuscular dysplasia CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohsen Basiri M.D.

Overview

Computed tomography angiography (CTA) has really excellent diagnostic exactness for FMD of the renal arteries.

CTA may use in the diagnosis of FMD of the cervicocephalic arteries and to find associated intracranial lesions.

Computed Tomography Angiography

  • CTA and MRA, both have good sensitivity and specificity in detecting FMD-related RAS lesions, but due to better spatial resolution of CTA than MRA, CTA is the recommended imaging technique to confirm the diagnosis of renal artery FMD.[1],

In addition, CTA can detect distal lesions, small calcifications, and determining discrimination of atherosclerotic vs. FMD lesions in older patients, and may thus be preferred to MRA.[2]

  • the disadvantages included
    • Allergic reactions to iodinated contrast medium.
    • Nephrotoxicity
    • Exposing patients to irradiation

References

  1. G. Boudewijn C. Vasbinder, Patricia J. Nelemans, Alfons G. H. Kessels, Abraham A. Kroon, Jeffrey H. Maki, Tim Leiner, Frederik J. A. Beek, Michael B. J. M. Korst, Karin Flobbe, Michiel W. de Haan, Willem H. van Zwam, Cornelis T. Postma, M. G. Myriam Hunink, Peter W. de Leeuw & Jos M. A. van Engelshoven (2004). "Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis". Annals of internal medicine. 141 (9): 674–682. PMID 15520423. Unknown parameter |month= ignored (help)
  2. Sheela T. Patel, Joseph L. Sr Mills, Gerlinde Tynan-Cuisinier, Kaoru R. Goshima, Alex Westerband & John D. Hughes (2005). "The limitations of magnetic resonance angiography in the diagnosis of renal artery stenosis: comparative analysis with conventional arteriography". Journal of vascular surgery. 41 (3): 462–468. doi:10.1016/j.jvs.2004.12.045. PMID 15838481. Unknown parameter |month= ignored (help)

Template:WH Template:WS